NCT07283666

Brief Summary

Investigators will evaluate the effectiveness of an audit and feedback performance improvement strategy in which cardiology providers receive quarterly emails on ambulatory quality improvement goals.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,000

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Dec 2024Jul 2026

Study Start

First participant enrolled

December 19, 2024

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 16, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

1.3 years

First QC Date

December 4, 2025

Last Update Submit

December 4, 2025

Conditions

Heart Failure With Reduced Ejection FractionAtrial Fibrillation

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients eligible for medications who are prescribed these medications

    Day 1

Secondary Outcomes (2)

  • Percentage of patients with HFrEF prescribed aldosterone antagonists

    Day 1

  • Percentage of patients with Afib prescribed oral anticoagulants

    Day 1

Study Arms (2)

Quarterly Emails

Quarterly emails on performance will be sent.

Control

Usual Care (no emails on performance).

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients seen by a cardiology provider in the ambulatory setting.

You may qualify if:

  • Active diagnosis of atrial fibrillation
  • CHADS2VASC of at least 2 in males and at least 3 in females
  • Outpatient cardiology visit in past 3 months
  • Most recent EF ≤40
  • Age 18-90
  • Outpatient cardiology visit in past 3 months

You may not qualify if:

  • LAAO device
  • Hemorrhagic Stroke
  • SBP\<90
  • eGFR\<30
  • Potassium\>5
  • Active allergy to MRA
  • Acknowledge reason on heart failure alert
  • Mechanical circulatory device
  • Cardiac amyloid diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Amrita Mukhopadhyay, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2025

First Posted

December 16, 2025

Study Start

December 19, 2024

Primary Completion

April 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

December 16, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

This is a quality improvement (QI) project and individual participant data (IPD) will not be shared with other researchers.

Locations

US(1)